AlphaFold predicted structure
CARMIL2 · Q6F5E8

Mean pLDDT
61.1/ 100
Low
1,435 residues
Confidence breakdown
- Very high(≥ 90)12%
- Confident(70–90)40%
- Low(50–70)8%
- Very low(< 50)40%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
capping protein regulator and myosin 1 linker 2
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
COVID-19 research
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalsevere combined immunodeficiency due to CARMIL2 deficiency
combined immunodeficiency
severe combined immunodeficiency
Combined T and B cell immunodeficiency
immunodeficiency disease
Immunodeficiency
immune system disorder
Chronic colitis
autosomal recessive congenital ichthyosis
hereditary disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Capping protein, Arp2/3 and myosin-I linker protein 2
Cell membrane-cytoskeleton-associated protein that plays a role in the regulation of actin polymerization at the barbed end of actin filaments. Prevents F-actin heterodimeric capping protein (CP) activity at the leading edges of migrating cells, and hence generates uncapped barbed ends and enhances actin polymerization (PubMed:26466680). Plays a role in cell protrusion formations; involved in cell polarity, lamellipodial assembly, membrane ruffling and macropinosome formations (PubMed:19846667, PubMed:26466680, PubMed:26578515). Involved as well in cell migration and invadopodia formation during wound healing (PubMed:19846667, PubMed:26466680, PubMed:26578515). Required for CD28-mediated stimulation of NF-kappa-B signaling, involved in naive T cells activation, maturation into T memory cells, and differentiation into T helper and T regulatory cells (PubMed:27647348, PubMed:27647349, PubMed:28112205)
CARMIL2 · Q6F5E8

Mean pLDDT
61.1/ 100
Low
1,435 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0